Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecord History now displays Revision: v3.6.3, replacing v3.6.2. This appears to be a small platform update reflected in the page metadata rather than a change to study information.SummaryDifference0.1%

- Check24 days agoChange DetectedThe record history shows a newer revision label (v3.6.2) replacing the old v3.6.0. This indicates the page version was updated in the history tracking.SummaryDifference0.1%

- Check38 days agoChange DetectedRecruitment status is updated to indicate no longer looking for participants. The record revision is updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

- Check45 days agoChange DetectedA new revision entry v3.5.5 was added to the study history, and the previous revision v3.5.4 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays the current site revision as v3.5.4, replacing the previous v3.5.3. This indicates a minor UI/backend update and does not modify the study record content or its results.SummaryDifference0.1%

- Check74 days agoChange DetectedRecord history now displays the study as Completed with updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous Active, not recruiting label. New version/date entries accompany the update.SummaryDifference0.6%

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.